My Portfolio
+
LINK YOUR PORTFOLIO

Ucb SA UCB-BE:Euronext Brussels

*Data is delayed | Exchange | EUR
Last | 5:35 PM CEST
251.90quote price arrow up+3.60 (+1.45%)
Volume
187,603
52 week range
153.65 - 289.50
Loading...
  • Open246.00
  • Day High252.50
  • Day Low244.20
  • Prev Close248.30
  • 52 Week High289.50
  • 52 Week High Date02/19/26
  • 52 Week Low153.65
  • 52 Week Low Date06/19/25

Key Stats

  • Market Cap48.996B
  • Shares Out194.51M
  • 10 Day Average Volume0.27M
  • Dividend1.45
  • Dividend Yield0.58%
  • Beta0.88

KEY STATS

  • Open246.00
  • Day High252.50
  • Day Low244.20
  • Prev Close248.30
  • 52 Week High289.50
  • 52 Week High Date02/19/26
  • 52 Week Low153.65
  • 52 Week Low Date06/19/25
  • Market Cap48.996B
  • Shares Out194.51M
  • 10 Day Average Volume0.27M
  • Dividend1.45
  • Dividend Yield0.58%
  • Beta0.88

RATIOS/PROFITABILITY

  • EPS (TTM)8.19
  • P/E (TTM)30.75
  • Fwd P/E (NTM)-
  • EBITDA (TTM)2.576B
  • ROE (TTM)14.91%
  • Revenue (TTM)7.741B
  • Gross Margin (TTM)74.29%
  • Net Margin (TTM)20.13%
  • Debt To Equity (MRQ)20.67%

EVENTS

  • Earnings Date-
  • Ex Div Date05/04/2026
  • Div Amount1.45
  • Split Date-
  • Split Factor-

Profile

MORE
Ucb SA is a Belgium-based biopharmaceutical and specialty chemical company that specializes in two therapeutic areas: diseases of the central nervous system (CNS) and immunology. In the area of central nervous system disorders, the Company is focused on epilepsy, diabetic neuropathic pain, multiple sclerosis, fibromyalgia, restless legs syndrome and Parkinson’s disease, and the area of immunology includes, bone loss disorders, Crohn’s disease, rheumatoid arthritis and...
Jonathan Peacock
Independent Non-Executive Chairman of the Board
Sandrine Dufour
Executive Vice President, Chief Financial Officer, Member of the Executive Committee
Alistair Henry
Executive Vice President, Chief Scientific Officer, Member of the Executive Committee
Emmanuel Caeymaex
Executive Vice President, Patient Evidence, Member of the Executive Committee
Fiona du Monceau
Executive Vice President - Patient Impact, Member of the Executive Committee
Address
ALLEE DE LA RECHERCHE 60
Anderlecht
1070
Belgium